Literature DB >> 15190676

Prion disease and Alzheimer's disease: pathogenic overlap.

Rudy J Castellani1, George Perry, Mark A Smith.   

Abstract

Prion diseases are widely recognized for their transmissibility, and it is this feature that has been studied most extensively. In recent years, public health concerns over the transmission of animal forms of prion disease, such as bovine spongiform encephalopathy and chronic wasting disease, to humans has only augmented the notion that prion diseases are primarily infectious. Yet within the spectrum of human prion diseases, often overlooked is the fact that the overwhelming majority of cases are age-dependent sporadic, or inherited processes. Closer examination of the pathophysiological processes involved in prion disease further indicates a neurodegenerative, rather than infectious disease. Indeed, the age requirement, the numerous kindreds carrying point mutations in an amyloidogenic protein, the copper binding properties of the amyloidogenic protein, the evidence of free radical damage, the presence of polymorphisms that influence disease susceptibility, the formation of amyloid plaques, and in some cases the presence of neurofibrillary pathology, are features common to both prion disease and Alzheimer's disease. Therefore, while transmissibility will continue to be a major subject of prion disease research, we suspect that further characterization of its pathophysiological mechanisms will only substantiate the notion that prion disease is fundamentally a neurodegenerative process.

Entities:  

Mesh:

Year:  2004        PMID: 15190676

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  6 in total

1.  Generation and propagation of yeast prion [URE3] are elevated under electromagnetic field.

Authors:  Hui-Yong Lian; Kang-Wei Lin; Chuanjun Yang; Peng Cai
Journal:  Cell Stress Chaperones       Date:  2017-12-06       Impact factor: 3.667

2.  Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting.

Authors:  M Preusser; T Ströbel; E Gelpi; M Eiler; G Broessner; E Schmutzhard; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

3.  The Brain NO Levels and NOS Activities Ascended in the Early and Middle Stages and Descended in the Terminal Stage in Scrapie-Infected Animal Models.

Authors:  Li-Na Chen; Jing Sun; Xiao-Dong Yang; Kang Xiao; Yan Lv; Bao-Yun Zhang; Wei Zhou; Cao Chen; Chen Gao; Qi Shi; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

4.  Early-onset Alzheimer's disease patient with prion (PRNP) p.Val180Ile mutation.

Authors:  Eva Bagyinszky; Min Ju Kang; Jungmin Pyun; Vo Van Giau; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-16       Impact factor: 2.570

5.  Functional genomics approach for identification of molecular processes underlying neurodegenerative disorders in prion diseases.

Authors:  Urmila Basu; Le Luo Guan; Stephen S Moore
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

6.  Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9.

Authors:  Lech Kaczmarczyk; Ylva Mende; Branko Zevnik; Walker S Jackson
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.